DD226285A5 - Verfahren zur herstellung von 1,4-dihydropyridinen - Google Patents

Verfahren zur herstellung von 1,4-dihydropyridinen Download PDF

Info

Publication number
DD226285A5
DD226285A5 DD84265515A DD26551584A DD226285A5 DD 226285 A5 DD226285 A5 DD 226285A5 DD 84265515 A DD84265515 A DD 84265515A DD 26551584 A DD26551584 A DD 26551584A DD 226285 A5 DD226285 A5 DD 226285A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
methyl
compounds
ethoxycarbonyl
alkyl
Prior art date
Application number
DD84265515A
Other languages
German (de)
English (en)
Inventor
David Alker
Peter E Gross
Simon F Campell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838319886A external-priority patent/GB8319886D0/en
Priority claimed from GB848400354A external-priority patent/GB8400354D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of DD226285A5 publication Critical patent/DD226285A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Registering, Tensioning, Guiding Webs, And Rollers Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DD84265515A 1983-07-23 1984-07-20 Verfahren zur herstellung von 1,4-dihydropyridinen DD226285A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838319886A GB8319886D0 (en) 1983-07-23 1983-07-23 Therapeutic agents
GB848400354A GB8400354D0 (en) 1984-01-07 1984-01-07 Therapeutic agents

Publications (1)

Publication Number Publication Date
DD226285A5 true DD226285A5 (de) 1985-08-21

Family

ID=26286678

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84265515A DD226285A5 (de) 1983-07-23 1984-07-20 Verfahren zur herstellung von 1,4-dihydropyridinen

Country Status (21)

Country Link
US (1) US4568677A (xx)
EP (1) EP0132375B1 (xx)
AT (1) ATE44146T1 (xx)
AU (1) AU547188B2 (xx)
CA (1) CA1265796A (xx)
CS (1) CS241549B2 (xx)
DD (1) DD226285A5 (xx)
DE (1) DE3478746D1 (xx)
DK (1) DK170069B1 (xx)
ES (1) ES8700856A1 (xx)
FI (1) FI79105C (xx)
GR (1) GR82230B (xx)
HU (1) HU212133B (xx)
IE (1) IE58443B1 (xx)
IL (1) IL72475A (xx)
NO (1) NO161174C (xx)
NZ (1) NZ208954A (xx)
PH (1) PH20479A (xx)
PL (1) PL142659B1 (xx)
PT (1) PT78958B (xx)
YU (1) YU43738B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
GR851819B (xx) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
GB8501395D0 (en) * 1985-01-19 1985-02-20 Pfizer Ltd Dihydropyridine anti-ischaemic & anti-hypertensive agents
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
JPS61227567A (ja) * 1985-04-01 1986-10-09 Eisai Co Ltd 1,4−ジヒドロピリジン誘導体
WO1987000836A1 (en) * 1985-08-06 1987-02-12 Boehringer Biochemia Robin S.P.A. Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines
IT1201454B (it) * 1985-08-19 1989-02-02 Boehringer Biochemia Srl 1,4-diidropiridine-2-sostituite
GB8526411D0 (en) * 1985-10-25 1985-11-27 Pfizer Ltd Dihydropyridines
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
US4654372A (en) * 1986-01-10 1987-03-31 Warner-Lambert Company Method for using verapamil for treating stroke
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US20070066619A1 (en) * 2002-10-07 2007-03-22 Artesian Therapeutics, Inc. Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
EP1554267A1 (en) * 2002-10-07 2005-07-20 Artesian Therapeutics, Inc. Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
CA2586870A1 (en) * 2004-11-10 2006-05-18 Synta Pharmaceuticals Corp. Il-12 modulatory compounds
CN115557883A (zh) * 2022-10-28 2023-01-03 常州制药厂有限公司 一种氨氯地平的合成工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
IE841905L (en) 1985-01-23
FI842911A (fi) 1985-01-24
NO842987L (no) 1985-01-24
AU3089984A (en) 1985-01-24
IL72475A0 (en) 1984-11-30
HU212133B (en) 1996-05-28
CS557084A2 (en) 1985-07-16
DE3478746D1 (en) 1989-07-27
FI842911A0 (fi) 1984-07-19
YU43738B (en) 1989-10-31
EP0132375B1 (en) 1989-06-21
EP0132375A3 (en) 1987-07-01
ES8700856A1 (es) 1986-11-16
PH20479A (en) 1987-01-16
FI79105C (fi) 1989-11-10
US4568677A (en) 1986-02-04
AU547188B2 (en) 1985-10-10
PT78958A (en) 1984-08-01
CA1265796A (en) 1990-02-13
NO161174C (no) 1989-07-12
YU130584A (en) 1986-12-31
PL248857A1 (en) 1985-08-27
EP0132375A2 (en) 1985-01-30
IL72475A (en) 1987-10-20
FI79105B (fi) 1989-07-31
CS241549B2 (en) 1986-03-13
DK355784D0 (da) 1984-07-20
PL142659B1 (en) 1987-11-30
HUT36113A (en) 1985-08-28
GR82230B (xx) 1984-12-13
DK170069B1 (da) 1995-05-15
ES534505A0 (es) 1986-11-16
IE58443B1 (en) 1993-09-22
NO161174B (no) 1989-04-03
ATE44146T1 (de) 1989-07-15
NZ208954A (en) 1986-11-12
PT78958B (en) 1986-10-21
DK355784A (da) 1985-01-24

Similar Documents

Publication Publication Date Title
DD226285A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
DE602004007239T2 (de) 4-AMINOTHIENO[2,3-d] PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7-INHIBITOREN
EP0103796B1 (de) Neue Dihydropyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE60024480T2 (de) Thiazol und imidazo[4,5-b]pyridin verbindungen und ihre verwendung als pharmazeutika
DE69816608T2 (de) 1h-pyrazolo[3,4-d]pyrimidine-4,6-dione als inhibitoren für die vermehrung von t-zellen
DE69010232T2 (de) 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DD218887A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
DD213920A5 (de) Verfahren zur herstellung von dihydropyridinen
DE3874358T2 (de) 4-(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
DD211340A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
CH635586A5 (de) Verfahren zur herstellung von 1,3-dihydroimidazo(4,5-b)pyridin-2-onen.
DE2149249B2 (de) 4-Amino-6-arylpyrimidine
DD215544A5 (de) Verfahren zur herstellung von dihydropyridinen
DE3851856T2 (de) 1,4-Dihydropyridin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE10237883A1 (de) Substituierte Isoxazolderivate und ihre Verwendung in der Pharmazie
DE3615180C2 (de) Disubstituierte 1,4-Piperazinylderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE2804519C2 (xx)
DE3782378T2 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
DD236928A5 (de) Verfahren zur herstellung neuer 1,2,4-triazolo-carbamate
DE3586817T2 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE2322350A1 (de) 1,8-naphthyridin-2(1h)-on-derivate und verfahren zu ihrer herstellung
DE3432985C2 (xx)
DD201594A5 (de) Verfahren zur herstellung von neuen polyazaheterocyclischen verbindungen
DD242406A5 (de) 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee